Bob Proulx Discusses Imagion's Recent Progress with Boardroom Media

Funds raised in Imagion’s recent Rights Issue will be used to fund the first-in-human trials for the Company’s MagSense technology. Listen to CEO Bob Proulx…


Hear Bob Proulx Interviewed by Health Professional Radio

Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on…


Pre-IPO Investor Conference Call

On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on…